01 · The Question
What Exactly Has Been Approved When Your Study Receives Ethics Approval?
Receiving an ethics approval letter can feel like crossing the final administrative hurdle before data collection. Your protocol has been reviewed, your consent materials have been accepted, and you finally have permission to begin. Does that mean the ethics part is essentially finished?
Not quite. Ethics approval is better understood as authorization to conduct the study that was reviewed and approved, under the conditions attached to that approval. It is not a general license to modify recruitment, instruments, procedures, participant populations, study sites, or other approved elements whenever circumstances change.
This distinction matters because studies rarely unfold exactly as imagined on paper. Recruitment may be slower than expected. An interview question may prove awkward. A new site may become available. A researcher may realize that collecting one additional variable would be useful. Some adjustments may be permissible through relatively simple institutional processes, while others require prospective ethics review. The researcher should not decide that boundary solely on the basis of whether a change seems harmless or convenient.
03 · What You Need to Know
Ethics Approval Applies to an Approved Version of Your Study
Approval Is Attached to What the Ethics Committee Reviewed
An ethics committee does not ordinarily approve a research idea in the abstract. It reviews information describing how the research will actually be conducted. Depending on the study and the review system, that may include the protocol, participant population, eligibility criteria, recruitment procedures, consent process, study instruments, data collection procedures, privacy and confidentiality safeguards, study sites, and other supporting documents.
The resulting approval therefore has boundaries. The practical question after approval is not simply, “Is my research project approved?” A more useful question is, “Is what I am about to do covered by what was approved?”
This principle appears clearly in major research oversight frameworks. U.S. HHS and FDA requirements provide that changes to approved research generally may not be initiated without prior IRB review and approval, except when a change is necessary to eliminate an apparent immediate hazard to participants. WHO's Research Ethics Review Committee similarly has a formal process for requesting amendments to approved protocols. Requirements differ across systems, so your own approval letter, ethics committee procedures, institutional policies, sponsor requirements, and applicable regulations remain controlling for your study.
The Approved Protocol Is Not Merely Paperwork
Researchers sometimes treat the protocol submitted for ethics review as a document needed to obtain permission, while treating the “real study” as something that can subsequently evolve independently. That creates a compliance problem. The protocol and associated approved materials define important aspects of the research that the committee evaluated when deciding whether the study was ethically acceptable.
For clinical trials conducted under ICH Good Clinical Practice, the current ICH E6(R3) guideline expressly states that investigators should comply with the protocol, GCP, and applicable regulatory requirements. It also requires protocol deviations to be documented and addresses circumstances in which deviation may be necessary to eliminate an immediate hazard to trial participants.
The exact obligations for a questionnaire study at a university may differ substantially from those for a regulated clinical trial. The broader lesson nevertheless remains useful: approval is tied to the study as reviewed, rather than simply to the title of the project or the researcher conducting it.
Approval May Cover More Than the Main Protocol
The protocol is often only part of the approved study package. Consent forms, participant information sheets, recruitment advertisements, questionnaires, interview guides, scripts, and other materials may themselves have been reviewed and approved.
That means a researcher can remain faithful to the broad study design while still departing from approved materials. For example, changing recruitment language, adding substantive questions to an interview guide, or altering information given during consent may raise a post-approval issue even if the research question has not changed.
Approved research
The study and associated materials as authorized by the ethics committee, subject to the approval's stated conditions and applicable requirements.
Your research project generally
The broader project may contain possibilities, ideas, or later adjustments that were never included in the materials reviewed by the ethics committee.
Not Every Adjustment Is Treated the Same Way
Recognizing that approval has boundaries does not mean every typo correction or administrative adjustment necessarily requires a new full ethics review. Ethics systems commonly distinguish among changes based on their nature and significance, but the terminology, thresholds, submission procedures, and review pathways are not universal.
A proposed change may therefore need an amendment, notification, administrative processing, expedited review, full committee review, or no additional ethics action under the applicable rules. Determining whether a change requires an ethics amendment should be based on the requirements governing your study rather than on an informal judgment that the change is “minor.”
Even the concept of a minor change depends on the relevant framework and institutional procedure. If that classification matters, verify how apparently minor research changes are handled by the ethics committee responsible for your study.
Common Operational Changes Can Still Matter Ethically
Some of the most tempting changes arise from ordinary practical problems rather than from deliberate redesign. Perhaps recruitment is too slow, so you want to advertise through another channel. Perhaps the target sample is difficult to reach, so you want to increase the sample size. Perhaps another institution offers access to suitable participants. Perhaps an interview question consistently confuses respondents.
These may sound like operational adjustments, but they can alter matters that were part of the ethics review. A new recruitment method, for example, may change who encounters the invitation, how privacy is protected, or whether potential participants experience pressure to participate. Researchers should therefore check the applicable process before changing approved recruitment methods.
The same caution applies when you want to change the approved sample size, add or remove a research site, or modify participant-facing materials. The relevant question is not whether the researcher believes the revised approach remains ethical. It is whether the proposed activity remains within the authorization already granted or requires further review.
Ethics Approval Can Carry Conditions and Continuing Responsibilities
An approval letter may impose conditions or identify responsibilities that continue after the study begins. Depending on the ethics system and the nature of the research, these can include requirements concerning amendments, reporting, adverse events or unanticipated problems, deviations, progress reports, continuing review, renewal, study closure, document retention, or other oversight activities.
These requirements vary considerably. For example, WHO's own Ethics Review Committee describes approval as being provided for a limited period, usually one year, and requires continuing review for projects under its system. By contrast, not every study governed by every contemporary regulatory framework necessarily undergoes annual continuing review. Researchers should therefore avoid turning one organization's procedure into a universal rule.
Watch Out
Do not assume that because a proposed change appears to reduce risk, improve the study, or leave the research question unchanged, you may implement it immediately. Whether prior review is required depends on the nature of the change and the rules governing your study.
There Is an Important Exception for Immediate Hazards in Some Frameworks
Some major regulatory and Good Clinical Practice frameworks recognize that participant protection may occasionally require immediate action before prospective approval can be obtained. Under U.S. HHS and FDA requirements, changes necessary to eliminate apparent immediate hazards to research participants are an exception to the general requirement for prior IRB review and approval. ICH E6(R3) similarly addresses deviations necessary to eliminate immediate hazards to trial participants and requires subsequent communication and reporting.
This is a safety exception, not a shortcut for inconvenient amendment procedures. It should not be stretched to cover ordinary methodological improvements, recruitment difficulties, scheduling problems, or changes made simply because obtaining prospective review would take time.
04 · A Practical Example
When a Small Practical Improvement Changes the Approved Study
Hypothetical Example
A researcher wants to improve recruitment after ethics approval
A researcher receives ethics approval for an interview study recruiting university students through email invitations sent by designated university offices. Recruitment is much slower than expected. A colleague suggests posting the invitation in several large student social-media groups instead.
Approved plan
Recruitment occurs through the method described in the approved materials.
Practical problem
The approved method is producing too few volunteers.
Proposed solution
The researcher wants to use additional social-media recruitment channels.
Ethics question
Is the new recruitment method already covered by the approval, or does the applicable ethics process require notification or prospective approval?
Action
The researcher checks the approved documents and the responsible ethics committee's requirements before implementing the new method.
The point is not that social-media recruitment is inherently problematic. It may be entirely acceptable. The issue is that its ethical acceptability and its authorization under an existing approval are separate questions. A researcher should not convert “I think this is ethically fine” into “therefore, it is already approved.”
06 · What This Means for You
Treat Approval as the Authorized Version of the Study, Not the End of Ethics Oversight
Once approval is granted, keep the final approved protocol, approval letter, approved participant materials, and any version-controlled supporting documents accessible to the research team. When the study changes in practice, compare the proposed activity with those materials rather than relying on memory.
If there is a meaningful difference, identify the applicable institutional procedure before acting. This is particularly important when the proposed change affects participants, recruitment, consent, eligibility, interventions or procedures, data collection, privacy, confidentiality, study sites, or other matters that formed part of the original review.
A simple decision framework
If what you plan to do is clearly within the currently approved protocol and documents
Follow the approved procedure and any continuing conditions attached to the approval.
If you want to change something that was reviewed or described in the approved materials
Check the ethics committee's amendment, modification, or notification requirements before implementing the change.
If you are unsure whether the difference is significant enough to require review
Ask the responsible ethics office or follow its formal determination process rather than making the classification yourself.
If an immediate participant hazard requires urgent action
Protect the participant first and follow the emergency deviation and reporting requirements applicable to your study.
If the departure has already happened
Document what occurred and determine the applicable deviation, noncompliance, and reporting requirements rather than attempting to treat prior conduct as prospectively approved.
This approach also helps when a study gradually changes through many seemingly small decisions. If the work begins to look materially different from the approved protocol, the issue may no longer be one isolated modification. Researchers should recognize when the actual study is drifting away from the approved protocol and address the discrepancy before it becomes routine practice.
07 · A Quick Checklist
Before Doing Something Differently From the Approved Study
Before implementing a change, check:
Compare the proposed activity with the latest approved protocol and supporting documents.
Check the approval letter for conditions, expiration information, reporting obligations, or other post-approval requirements.
Determine whether the proposed change affects participants, recruitment, consent, eligibility, procedures, data collection, privacy, confidentiality, study sites, or other reviewed elements.
Consult the responsible ethics committee's current amendment or modification policy rather than assuming that a change is minor.
Obtain prospective review or approval when required before implementing the change.
Keep clear version control so the research team knows which protocol, consent form, instrument, and other documents are currently approved.
If an unplanned departure has already occurred, document it and check whether it must be reported.
If participant safety requires an immediate departure, follow the applicable emergency procedures and subsequent reporting requirements.